By Allison Sit The FDA recently issued warning letters to three companies for selling unapproved new drugs for mole and skin tag removal, according to a news release. Amazon.com, Ariella…
Read More
Sarcoidosis (and Other Granulomatous Diseases) Host: Adam Friedman, MD, FAAD Speaker: Misha Rosenbach, MD This ongoing evidence-based series from George Washington University, hosted by Dr. Adam Friedman, is comprised…
Read More
Shape magazine was one of several publications that highlighted studies from the Journal of Drugs in Dermatology this month. The magazine’s article, “Does Using Castor Oil for Hair Growth Actually…
Read More
iTunes Google Play Stitcher TuneIn Amy Paller, MD & Adam Friedman, MD, FAAD For the millions of Atopic Dermatitis suffers, recent months have heralded a new age of both topical…
Read More
iTunes Google Play Stitcher TuneIn Amy Paller, MD & Adam Friedman, MD, FAAD To those who say you can only learn from your own experience, we call bluff. Dr. Amy…
Read More
By Allison Sit Babies may have a lower risk of eczema if their mothers take vitamin D during pregnancy, according to a new study in the British Journal of Dermatology.…
Read More
The June issue of the Journal of Drugs in Dermatology made several headlines with Healio recently. One article, “Rosacea More Common Than Expected Among Patients With Skin of Color,” was…
Read More
iTunes Google Play Stitcher TuneIn Shawn Kwatra, MD & Adam Friedman, MD, FAAD Pruritus is a pain for all those involved. Both a symptom and a disease simultaneously, one…
Read More
iTunes Google Play Stitcher TuneIn Shawn Kwatra, MD & Adam Friedman, MD, FAAD Being awarded a grant can seem insurmountable at times, with rejections and pink slips abound, but…
Read More
By Allison Sit May marks the 20th anniversary of the Journal of Drugs in Dermatology. Launched in 2002 by dermatologist Perry Robins, MD, the JDD is now considered the fastest…
Read More
Healio published several articles recently about studies from the May issue of the Journal of Drugs in Dermatology. One article, “COVID-19 Precautions Linked with Delays in Skin Cancer Treatment,” was…
Read More
By Allison Sit The FDA has approved Olumiant (baricitinib) as a first-in-disease systemic treatment for adults with severe alopecia areata. Olumniant is a once-daily, oral JAK inhibitor. "People with alopecia…
Read More
